Aeluma is trading 5.33% up at $18.17, with no clear catalyst identified.

  • No new company-specific announcement dated August 11 was identified.
  • The stock is recovering from a 5.74% decline to $17.25 on August 10.
  • Recent coverage references the July 29 CHIPS Act letter of intent for up to $30 million, predating today’s move; broader U.S. markets are lower, so market-wide sentiment does not clearly explain the gain.